Volume 29, Issue 6 (Iran South Med J 2026)                   Iran South Med J 2026, 29(6): 465-475 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Vahidi M R, Abdollahi G, Mohtashami A, Jafari M R, Vaghebin R, Mousavi M J. Regression of an Endometrioma with Concomitant Adenomyosis, and Deep Infiltrating Endometriosis (DIE) Following an Integrative Traditional Persian Medicine and Conventional Approach: A Case Report. , Iran South Med J. 2026; 29 (6) :465-475
URL: http://ismj.bpums.ac.ir/article-1-2716-en.html
1- Student Research Committee, Bushehr University of Medical Sciences, Bushehr, Iran
2- Department of Iranian Traditional Medicine, School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran
3- Department of Immunology and Allergy, School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran , M.j.mousavi@bpums.ac.ir
Abstract:   (16 Views)
Background: Ovarian endometrioma, particularly when accompanied by adenomyosis and deep infiltrating endometriosis (DIE), represents one of the most challenging presentations of endometriosis, as it may be refractory to standard hormonal therapies. This case report aimed to describe the effectiveness of a multimodal integrative approach that combined Traditional Persian Medicine (TPM) and conventional medicine in managing a patient with complex endometriosis.
Case Presentation: A 41-year-old woman presented with debilitating pelvic pain that prevented her from sitting and severe dysmenorrhea after six months of unsuccessful treatment with dienogest (Verogest). An ovarian cyst had initially been identified during a routine ultrasonographic examination. Approximately four months later, follow-up transvaginal ultrasonography demonstrated a 50-mm left ovarian endometrioma, with findings consistent with focal adenomyosis of the posterior uterine wall and deep endometriosis involving the left ovarian fossa and left uterosacral ligament. Baseline serum level of CA-125 was 95 U/mL. The patient underwent a
six-month integrative treatment protocol consisting of continued dienogest therapy alongside standardized TPM oral formulations (Ma'al-Jubn-e Aftimooni powder, Monzej-e-Sawda decoction, Sekanjabin-e-Bozouri syrup, and Itrifal Muqil capsules), topical interventions (Four-Flower sitz bath [Abzan-e Chahar-Gol] and chamomile oil application), and structured lifestyle modifications. One year after integrative treatment initiation, radiological follow-up demonstrated complete resolution of the ovarian endometrioma, complete regression of focal
adenomyosis, and disappearance of all DIE lesions. Concurrently, serum CA-125 decreased to 7 U/mL, and clinical remission was observed. Six months after discontinuation of all treatments, follow-up ultrasonography revealed mild structural recurrence, including a 14-mm ovarian cyst and mild bilateral ligament involvement; however, the patient remained completely asymptomatic, without pelvic pain or dysmenorrhea.

Conclusion: In this case report, an integrative approach consisting of conventional treatment and Traditional Persian Medicine interventions was associated with significant improvement in clinical, laboratory, and imaging findings. Moreover, the persistence of clinical remission despite mild structural recurrence may suggest a potential role for lifestyle modification and temperament-based interventions in sustaining the therapeutic response. These findings suggest that such an approach may be worthy of consideration as an adjunctive strategy in the management of complex and refractory presentations of endometriosis. Nevertheless, further clinical studies are needed to provide a more precise evaluation of the efficacy and safety of these interventions
Full-Text [PDF 682 kb]   (7 Downloads)    
Original: Case Report | Subject: Gynecology
Received: 2026/11/21 | Accepted: 2026/11/21 | Published: 2026/11/21

Send email to the article author


Rights and Permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2026 CC BY-NC 4.0 | Iranian South Medical Journal

Designed & Developed by: Yektaweb